The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Read More
In recognition of World Alzheimer’s Month, we spoke with CHÉOS researcher Dr. Rick Sawatzky about his use of Quality of Life data for improving the lives of older adults
This edition includes treatment of out-of-hospital cardiac arrest, implementation of mifepristone medical abortion, and non-traditional factors that contribute to type 2 diabetes
Many of us use Zoom on a daily basis. Here are some helpful tips to make the most of remote media opportunities.
New research from the CHÉOS Health Economics Program finds that market factors and pricing policies may be to blame
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
This COVID-19 special edition includes managing chronic kidney disease, facilitating transcatheter aortic valve implantation, and youth mental health and substance use
